Drug Resistant Tuberculosis News and Research

RSS
Three-day global symposium on Ebola virus, other infectious diseases

Three-day global symposium on Ebola virus, other infectious diseases

NPS MedicineWise calls all Australians to join the fight against antibiotic resistance

NPS MedicineWise calls all Australians to join the fight against antibiotic resistance

New therapy appears to help tinnitus patients cope better with phantom noise

New therapy appears to help tinnitus patients cope better with phantom noise

Johns Hopkins School of Nursing to launch new HIV curriculum for non-physician providers

Johns Hopkins School of Nursing to launch new HIV curriculum for non-physician providers

CRAG urges researchers to balance goal of shortening treatment for MDR-TB with patient safety

CRAG urges researchers to balance goal of shortening treatment for MDR-TB with patient safety

Viewpoints: Misreading Hobby Lobby; calmer climate for ACA; danger of tuberculosis, measles

Viewpoints: Misreading Hobby Lobby; calmer climate for ACA; danger of tuberculosis, measles

WHO's annual statistics report shows global life expectancy continues to increase

WHO's annual statistics report shows global life expectancy continues to increase

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

New policy report on multi-drug resistant tuberculosis

New policy report on multi-drug resistant tuberculosis

Viewpoints: Be careful what you pray for; health law 'freakouts;' concerns about imported drugs

Viewpoints: Be careful what you pray for; health law 'freakouts;' concerns about imported drugs

Tuberculosis control needs a complete and patient-centric solution

Tuberculosis control needs a complete and patient-centric solution

New consensus statements developed to help tackle drug-resistant TB

New consensus statements developed to help tackle drug-resistant TB

China manages to halve TB prevalence in 20 years

China manages to halve TB prevalence in 20 years

Active ingredient in vinegar can effectively kill mycobacteria

Active ingredient in vinegar can effectively kill mycobacteria

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Global atlas identifies greatest need for palliative care in low-and middle-income countries

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

McMaster vaccine offers new hopes for global fight against TB

McMaster vaccine offers new hopes for global fight against TB